The Greater Cannabis Company, Inc.

GCAN

US3916571033

Internet Services

Market Closed - OTC Markets Other stock markets 09:49:31 2024-04-29 am EDT			5-day change	1st Jan Change
0.0007 ^USD	0.00%		+16.67%	-22.22%

Apr. 01	The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

April 01, 2024 at 06:06 am EDT

The Greater Cannabis Company, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 0.188402 million compared to USD 0.360268 million a year ago.

Latest news about The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-13	CI
The Greater Cannabis Company, Inc. Auditor Raises 'Going Concern' Doubt	23-04-12	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Greater Cannabis Company, Inc. Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders	22-10-07	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-12	CI
The Greater Cannabis Company, Inc. Auditor Raises 'Going Concern' Doubt	22-04-11	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Greater Cannabis Company, Inc. Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy	21-11-08	CI
Greater Cannabis Company, Inc. Signs License and Research Agreement with share Zedek Scientific	21-11-08	CI
The Greater Cannabis Company, Inc. Announces Mark Radom Resigned from His Position of General Counsel of the Company, Effective Immediately	21-11-01	CI
The Greater Cannabis Company, Inc. Announces Resignation of David Tavor as Director	21-08-19	CI
GCANRx Signs Licensing Agreement with share Zedek Scientific for Innovative Neuropsychiatric Cannabinoid Therapy	21-08-19	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-18	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-26	CI
The Greater Cannabis Company, Inc. Announces Collaboration with Renowned Cannabis Research Lab	21-03-16	CI
The Greater Cannabis Company Announces Launch of Bob Ross Beauty and Cosmetics Products	20-11-23	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-19	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-17	CI

Chart The Greater Cannabis Company, Inc.

Duration

Period

Chart The Greater Cannabis Company, Inc.

More charts

Company Profile

The Greater Cannabis Company, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of cannabinoid therapeutics. The Company conducts medical research, and is pursuing clinical trials, to develop cannabis-based treatments for various medical conditions and their symptoms with an initial focus on neuropsychiatric disorders. The Company conducts clinical studies on and commercialize the cannabinoid-based therapeutic and concentrate on cannabis related investment and development opportunities through direct equity investments, joint ventures, licensing agreements or acquisitions. Its delivery technologies use a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, which provides needle free, intra-oral systemic drug delivery.

Sector

Internet Services

More about the company

Income Statement Evolution

More financial data

Sector Other Internet Services

	1st Jan change	Capi.
THE GREATER CANNABIS COMPANY, INC.	-22.22%	563K
TENCENT HOLDINGS LIMITED	+18.66%	414B
NETFLIX, INC.	+14.91%	242B
UBER TECHNOLOGIES, INC.	+9.47%	144B
AIRBNB, INC.	+19.18%	104B
PROSUS N.V.	+16.86%	83.87B
SPOTIFY TECHNOLOGY S.A.	+52.33%	57.64B
DOORDASH, INC.	+33.60%	53.37B
COSTAR GROUP, INC.	+5.85%	37.83B
NASPERS LIMITED	+15.64%	34.11B